Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -19.9% | -35.4% | 1 / 3 | +13.8% | -5.45 pp | -5.17 pp | +13.4% | 0.31 | 8.03 | 108 | +13,8% | 13,3 | −19,9% | 8.03 | 26.83 | −70,1% |
| Pts | 0 | 0 | 4 | 4 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 19.400 (close price on 2026-10-19)EPS (TTM): 2.416
Financial charts
1.Revenue & growth
VND bn108Q2/26
1.Revenue & growth
VND bn108Q2/26
2.Profit & growth
VND bn11,0Q2/26
3.Profit mix (Penman)
VND bn30,3Q2/26
4.Margins & cost structure
%31.6%Q2/26
5.Returns & cash cycle
% · days11.1%Q2/26
6.Earnings quality & cash
VND bn39,3Q2/26
7.Asset structure
VND bn414Q2/26
8.Funding & debt health
VND bn · times414Q2/26
9.Revenue backlog
VND bn2,31Q2/26
10.Valuation
times · %8,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %899Q2/26
Adjusted EPS growth, latest quarter
-33.8%
Average adjusted EPS growth, 3 quarters
-40.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26